A Nationwide Nested Case-Control Study Indicates an Increased Risk of Acute Interstitial Nephritis With Proton Pump Inhibitor Use

Kidney International - United States
doi 10.1038/ki.2014.74
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study

Frontiers in Pharmacology
Pharmacology
2018English

Increased Proton Pump Inhibitor and NSAID Exposure in Irritable Bowel Syndrome: Results From a Case-Control Study

BMC Gastroenterology
MedicineGastroenterology
2012English

Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study

Journal of the American Geriatrics Society
GerontologyGeriatrics
2017English

Letter: Proton Pump Inhibitor Use and Risk of Fracture

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Comment on “Proton Pump Inhibitor Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case–Control Analysis”

Drug Safety
ToxicologyPharmacology
2018English

Cefepime Induced Acute Interstitial Nephritis – A Case Report

BMC Nephrology
Nephrology
2015English

Proton Pump Inhibitor Use Is Associated With a Reduced Risk of Infection With Intestinal Protozoa

Wilderness and Environmental Medicine
EnvironmentalPublic HealthOccupational HealthSports ScienceEmergency Medicine
2017English

Acute Allergic Interstitial Nephritis After Use of Pantoprazole

CMAJ
Medicine
2009English

Fundic Gland Polyposis Associated With Proton-Pump Inhibitor Use

European Journal of Case Reports in Internal Medicine
Internal Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy